化學製藥Pharmaceutics

1、Development of anti-Globo H ADC against Cancer (Anti-Globo H抗體藥物複合體技術開發)

2、AXL Inhibitor as Anticancer Drug (AXL激酶抑制劑抗癌藥物)

3、Hedgehog inhibitor as an anti-cancer agent (Hedgehog抑制劑抗癌藥物開發)

 

生物製藥 Biologicsis

1、Development of Tissue Specific Activated Antibody for Central Nervous System (CNS) Related Diseases (組織專一性活化之中樞神經系統疾病抗體藥物開發)

2、High yield CHO production system(高產量CHO細胞表現系統)

3、Development of Anti-Mesothelin x CD3 BsAb for Mesothelin+ Cancer Therapy(抗mesothelin x CD3雙特異性抗體開發技術)

4、Tri-mannosyl Antibody: A Versatile Payload ADC Platform (CHO細胞生產均相醣基工程技術：三甘露醣抗體藥物複合體)

5、Anti- Human PD-L1 Antibodies (抗人類PD-L1抗體)

6、Development of CSF-1R Antibody Drug to Target Tumor Associated Macrophage for Cancer Immunotherapy (抑制腫瘤相關巨噬細胞之CSF-1R癌症抗體藥物開發)

7、Anti-Globo H mAb for Cancer Therapy (抗醣抗原Globo H單株抗體在癌症治療的應用)
8、Anti-Globo H Bispecific Antibody (抗醣抗原Globo H雙特異性抗體)
9、DCBPR1702, An Anti-Human TIM-3 Therapeutic Antibody in Preclinical Studies for Cancer Immunotherapy (DCBPR1702抗人類TIM-3抗體藥物用於癌症免疫治療之臨床前研究)